Your browser doesn't support javascript.
Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis.
Kravchenko, Dmitrij; Isaak, Alexander; Mesropyan, Narine; Bischoff, Leon M; Pieper, Claus C; Attenberger, Ulrike; Kuetting, Daniel; Zimmer, Sebastian; Hart, Christopher; Luetkens, Julian A.
  • Kravchenko D; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
  • Isaak A; Quantitative Imaging Lab Bonn, University Hospital Bonn, Bonn, Germany.
  • Mesropyan N; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
  • Bischoff LM; Quantitative Imaging Lab Bonn, University Hospital Bonn, Bonn, Germany.
  • Pieper CC; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
  • Attenberger U; Quantitative Imaging Lab Bonn, University Hospital Bonn, Bonn, Germany.
  • Kuetting D; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
  • Zimmer S; Quantitative Imaging Lab Bonn, University Hospital Bonn, Bonn, Germany.
  • Hart C; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
  • Luetkens JA; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
Front Cardiovasc Med ; 9: 1049256, 2022.
Article in English | MEDLINE | ID: covidwho-2141727
ABSTRACT

Background:

Mass COVID-19 vaccination campaigns have helped impede the COVID-19 pandemic. In rare cases, some vaccines have led to vaccine associated myocarditis in a specific subset of the population, usually young males. Cardiac magnetic resonance (CMR) can reliably diagnose vaccine associated myocarditis, but follow-up data of CMR proven acute myocarditis is scarce. Materials and

methods:

Nine patients with acute vaccine associated myocarditis underwent baseline and follow-up CMR examinations and were compared to baseline parameters at initial presentation and to a group of 20 healthy controls. CMR protocol included functional assessment, T1 and T2 mapping, T2 signal intensity ratio, strain feature tracking, and late gadolinium enhancement (LGE).

Results:

Myocarditis patients (n = 9, aged 24 ± 6 years, 8 males) underwent CMR follow-up after an average of 5.8 ± 4.3 months. All patients showed a complete resolution of visual myocardial edema while also demonstrating a reduction in overall LGE extent from baseline to follow-up (4.2 ± 2.1 vs. 0.9 ± 0.8%, p < 0.001), although visual LGE was still noted in all patients. Left ventricular ejection fraction was normal at baseline and at follow-up (58 ± 6 vs. 62 ± 4%, p = 0.10) as well as compared to a healthy control group (60 ± 4%, p = 0.24). T1 (1024 ± 77 vs. 971 ± 34 ms, p = 0.05) and T2 relaxations times (57 ± 6 vs. 51 ± 3 ms, p = 0.03) normalized at follow-up. Most patients reported a resolution of clinical symptoms, while two (22%) reported new onset of exertional dyspnea.

Conclusion:

Patients with COVID-19 vaccine associated acute myocarditis showed a complete, uncomplicated resolution of myocardial inflammation on follow-up CMR, which was associated with a near complete resolution of symptoms. Minor, residual myocardial scarring was present on follow-up LGE imaging. The long-term implications of the remaining myocardial scar-tissue after vaccine associated myocarditis remain unknown warranting further studies.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Language: English Journal: Front Cardiovasc Med Year: 2022 Document Type: Article Affiliation country: Fcvm.2022.1049256

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Language: English Journal: Front Cardiovasc Med Year: 2022 Document Type: Article Affiliation country: Fcvm.2022.1049256